This content is machine translated ACC Congress in San Diego “Universal antidote” of the future? An antidote to Factor Xa inhibitors is making great progress in clinical trials: Andexanet alfa. New results were presented at the American College of Cardiology Congress in San Diego: According…
View Post 3 min This content is machine translated Direct oral anticoagulants “Teaching Old Docs New Tricks?” Recently, I was discussing (as an older “doc”) with one of my marcoumar anticoagulated 87-year-old patients with atrial fibrillation, status post anterior myocardial infarction with akinesia, status post severe gastric…
View Post 4 min This content is machine translated New anticoagulants Questions of practical application are to be clarified The new anticoagulants rivaroxaban, apixaban, and dabigatran promise several benefits, but are not suitable for all patient populations. Various questions arise in primary care practice, which were discussed at this…
